-transparent.png){kind=logo}
A series of 2-phenylimidazo[2,1-b]benzothiazole derivatives was prepared and tested for immunological activities. Some of the compounds showed significant suppressive activity of delayed type hypersensitivity (DTH) without inhibition of humoral immunity in mice by oral administration. The most active compound was 2-(m-hydroxyphenyl)imidazo[2,1-b]benzothiazole (20).
Related Publications
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
November 1989,
Chemical & pharmaceutical bulletin,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
May 1988,
Il Farmaco; edizione scientifica,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
August 2018,
Bioorganic & medicinal chemistry letters,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
January 2022,
Medicinal chemistry (Shariqah (United Arab Emirates)),
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
October 2023,
Future medicinal chemistry,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
February 1980,
Journal of medicinal chemistry,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
February 2010,
European journal of medicinal chemistry,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
February 2008,
Journal of medicinal chemistry,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
August 1968,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
T Mase, and
H Arima, and
K Tomioka, and
T Yamada, and
K Murase
December 1976,
Il Farmaco; edizione scientifica,
